288 related articles for article (PubMed ID: 23406253)
1. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study.
Kim M; Kim DM; Park KH; Kim TW; Jeoung JW; Kim SH
Acta Ophthalmol; 2013 Jun; 91(4):e270-5. PubMed ID: 23406253
[TBL] [Abstract][Full Text] [Related]
2. Influence of intraocular pressure reduction on progression of normal-tension glaucoma with myopic tilted disc and associated risk factors.
Seol BR; Kim S; Kim DM; Park KH; Jeoung JW; Kim SH
Jpn J Ophthalmol; 2017 May; 61(3):230-236. PubMed ID: 28280945
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for progression of normal-tension glaucoma under β-blocker monotherapy.
Araie M; Shirato S; Yamazaki Y; Matsumoto C; Kitazawa Y; Ohashi Y;
Acta Ophthalmol; 2012 Aug; 90(5):e337-43. PubMed ID: 22551324
[TBL] [Abstract][Full Text] [Related]
4. Preperimetric normal tension glaucoma study: long-term clinical course and effect of therapeutic lowering of intraocular pressure.
Jeong JH; Park KH; Jeoung JW; Kim DM
Acta Ophthalmol; 2014 May; 92(3):e185-93. PubMed ID: 24456145
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
[TBL] [Abstract][Full Text] [Related]
7. Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment.
Sakata R; Aihara M; Murata H; Mayama C; Tomidokoro A; Iwase A; Araie M
J Glaucoma; 2013 Mar; 22(3):250-4. PubMed ID: 23059475
[TBL] [Abstract][Full Text] [Related]
8. Progression of visual field defects in eyes with different optic disc appearances in patients with normal tension glaucoma.
Nakazawa T; Shimura M; Ryu M; Himori N; Nitta F; Omodaka K; Doi H; Yasui T; Fuse N; Nishida K
J Glaucoma; 2012 Aug; 21(6):426-30. PubMed ID: 22314251
[TBL] [Abstract][Full Text] [Related]
9. Visual field progression differences between normal-tension and exfoliative high-tension glaucoma.
Ahrlich KG; De Moraes CG; Teng CC; Prata TS; Tello C; Ritch R; Liebmann JM
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1458-63. PubMed ID: 20042657
[TBL] [Abstract][Full Text] [Related]
10. [Study on relationship between control of intraocular pressure and systemic risk factor for visual field progression in normal-tension glaucoma].
Nakagami T; Yamazaki Y; Hayamizu F
Nippon Ganka Gakkai Zasshi; 2010 Jul; 114(7):592-7. PubMed ID: 20681254
[TBL] [Abstract][Full Text] [Related]
11. [A challenge to primary open-angle glaucoma including normal-pressure. Clinical problems and their scientific solution].
Sugiyama K
Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):233-67; discussion 268. PubMed ID: 22568103
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
13. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
14. Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers.
Sugiyama T; Kojima S; Ishida O; Ikeda T
Acta Ophthalmol; 2009 Nov; 87(7):797-800. PubMed ID: 19053956
[TBL] [Abstract][Full Text] [Related]
15. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.
Leung DY; Tham CC; Li FC; Kwong YY; Chi SC; Lam DS
Ophthalmology; 2009 Jul; 116(7):1250-6. PubMed ID: 19481813
[TBL] [Abstract][Full Text] [Related]
16. Clinical Course and Risk Factors for Visual Field Progression in Normal-Tension Glaucoma With Myopia Without Glaucoma Medications.
Han JC; Han SH; Park DY; Lee EJ; Kee C
Am J Ophthalmol; 2020 Jan; 209():77-87. PubMed ID: 31493404
[TBL] [Abstract][Full Text] [Related]
17. Does the enlargement of retinal nerve fiber layer defects relate to disc hemorrhage or progressive visual field loss in normal-tension glaucoma?
Nitta K; Sugiyama K; Higashide T; Ohkubo S; Tanahashi T; Kitazawa Y
J Glaucoma; 2011 Mar; 20(3):189-95. PubMed ID: 20577114
[TBL] [Abstract][Full Text] [Related]
18. Optic Disc Rotation as a Clue for Predicting Visual Field Progression in Myopic Normal-Tension Glaucoma.
Sung MS; Kang YS; Heo H; Park SW
Ophthalmology; 2016 Jul; 123(7):1484-93. PubMed ID: 27157844
[TBL] [Abstract][Full Text] [Related]
19. Comparison of visual field progression between relatively low and high intraocular pressure groups in normal tension glaucoma patients.
Lee J; Kong M; Kim J; Kee C
J Glaucoma; 2014; 23(8):553-60. PubMed ID: 23751927
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.
Tanna AP; Rademaker AW; Stewart WC; Feldman RM
Arch Ophthalmol; 2010 Jul; 128(7):825-33. PubMed ID: 20625041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
